title: Risk of Clostridium difficile Infection in Hematology-Oncology Patients Colonized With Toxigenic C. difficile.
abstract: The prevalence of colonization with toxigenic Clostridium difficile among patients with hematological malignancies and/or bone marrow transplant at admission to a 566-bed academic medical care center was 9.3%, and 13.3% of colonized patients developed symptomatic disease during hospitalization. This population may benefit from targeted C. difficile infection control interventions. Infect Control Hosp Epidemiol 2017;38:718-720.
authors.affiliation: 1Department of Population Health Sciences,University of Wisconsin School of Medicine and Public Health,Madison,Wisconsin.
authors.forename: Cara M
authors.initials: CM
authors.lastname: Cannon
authors.affiliation: 2Institute of Clinical and Translational Research,University of Wisconsin,Madison,Wisconsin.
authors.forename: Jackson S
authors.initials: JS
authors.lastname: Musuuza
authors.affiliation: 1Department of Population Health Sciences,University of Wisconsin School of Medicine and Public Health,Madison,Wisconsin.
authors.forename: Anna K
authors.initials: AK
authors.lastname: Barker
authors.affiliation: 3Division of Infectious Diseases,Department of Medicine,University of Wisconsin School of Medicine and Public Health,Madison,Wisconsin.
authors.forename: Megan
authors.initials: M
authors.lastname: Duster
authors.affiliation: 4Division of Hematology,Department of Medicine,University of Wisconsin School of Medicine and Public Health,Madison,Wisconsin.
authors.forename: Mark B
authors.initials: MB
authors.lastname: Juckett
authors.affiliation: 3Division of Infectious Diseases,Department of Medicine,University of Wisconsin School of Medicine and Public Health,Madison,Wisconsin.
authors.forename: Aurora E
authors.initials: AE
authors.lastname: Pop-Vicas
authors.affiliation: 3Division of Infectious Diseases,Department of Medicine,University of Wisconsin School of Medicine and Public Health,Madison,Wisconsin.
authors.forename: Nasia
authors.initials: N
authors.lastname: Safdar
mesh_terms: D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002353:Carrier State / Q000175:diagnosis* / Q000382:microbiology; D002511:Cephalosporins / Q000627:therapeutic use; D016360:Clostridioides difficile; D004761:Enterocolitis, Pseudomembranous / Q000175:diagnosis* / Q000382:microbiology; D005260:Female; D019337:Hematologic Neoplasms / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D010343:Patient Admission; D015995:Prevalence; D011446:Prospective Studies; D012307:Risk Factors
chemical_list: D000970:Antineoplastic Agents; D002511:Cephalosporins